SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.00010000.0%Aug 15 3:35 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pancho Villa who wrote (1005)2/1/1998 2:59:00 PM
From: KurtVedder  Read Replies (1) of 1359
 
<<With all due respect for Neuro, be aware of the fact that the track record of most newsletters isn't that great and that there is more at stake here than just knowing or seemingly knowing the technical side. As far as IPIC is concerned, Neuro followers are still loosing on this one.>>
Newsletters are just that. NEWSletters. They are there to provide information for the investor to analyze and then decide if he/she wishes to purchase the stock. If the news reported by the newsletter is thorough and accurate then it should be deemed an outstanding newsletter. In the case of Neuroinvestment NEWSletter, they have consistently provided excellent information regarding, among other neuro companies, IPIC. If someone purchases a stock because a newsletter says to then they have a lot to learn. Neuroinvestment is a fabulous resource for thoroughly understanding what you are buying. It, as well as all other newsletters, should not be judged on the stock performance of the companies they cover but rather on the wealth of information they provide. Plus, in the long run (which is the only way in which biotech's should be invested), I am confident that Neuroinvestment will outperform most, if not all, other newsletters in the field.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext